A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients

BACKGROUND: Iron deficiency anaemia is common in patients with chronic kidney disease, and intravenous iron is the preferred treatment for those on haemodialysis. The aim of this trial was to compare the efficacy and safety of iron isomaltoside 1000 (Monofer®) with iron sucrose (Venofer®) in haemodi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nephrol Dial Transplant
Autors principals: Bhandari, Sunil, Kalra, Philip A., Kothari, Jatin, Ambühl, Patrice M., Christensen, Jeppe H., Essaian, Ashot M., Thomsen, Lars L., Macdougall, Iain C., Coyne, Daniel W.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
Clinical Science
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4550440/
https://ncbi.nlm.nih.gov/pubmed/25925701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv096
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars